SGMT Sagimet Biosciences Inc. - Series A Common Stock
$6.59
가격 · 5월 20, 2026
기준 재무 정보 5월 12, 2026
52주 범위
$3–$11
42% of range
애널리스트 평점
BUY
18 analysts
목표 주가
$28
+332% upside
P/E (TTM)
-3.7
ROE
-42.3%
순이익률
—
SGMT 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$6.59
시가총액
—
P/E (TTM)
-3.7
EPS (TTM)
$-1.58
매출 (TTM)
$2M
배당 수익률
—
ROE
-42.3%
부채/자본
—
52주 범위
$3 – $11
SGMT 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$2M
2023-12-31
→
2023-12-31
EPS
$-1.58
2022-12-31
→
2025-12-31
잉여현금흐름
—
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
SGMT
동종업계 중앙값
P/E (TTM)
-3.7
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
SGMT
동종업계 중앙값
ROA
-36.9%
-33.2%
ROE
-42.3%
-62.6%
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
SGMT
동종업계 중앙값
Current Ratio (유동비율)
22.8
5.8
Quick Ratio (당좌 비율)
22.2
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
SGMT
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
SGMT
동종업계 중앙값
SGMT 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
18 명의 애널리스트
- 적극 매수 6 33.3%
- 매수 10 55.6%
- 보유 2 11.1%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
10 명의 애널리스트 · 2026-05-18
중앙값
$28.50
← 모든 목표가 하회
$6.59
저가
$8.00
고가
$49.00
중앙값 목표
$28.50
+332.5%
평균 목표
$28.50
+332.5%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.10%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.33 | $-0.38 | 0.05% |
| 2025년 12월 31일 | $-0.29 | $-0.41 | 0.12% |
| 2025년 9월 30일 | $-0.40 | $-0.39 | -0.01% |
| 2025년 6월 30일 | $-0.32 | $-0.52 | 0.20% |
| 2025년 3월 31일 | $-0.56 | $-0.68 | 0.12% |
동료 비교 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| SGMT | — | -3.7 | — | — | -42.3% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| REPL | $752M | -3.2 | — | — | -55.1% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| MNPR | — | — | — | — | — | — |
| FBRX | $353M | -5.8 | 106.6% | -2555.2% | -86.9% | — |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | — |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | — |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 13
| 지표 | 추세 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | · | · | $2M | |
| R&D Expense | $39M | $38M | $20M | |
| SG&A Expense | $18M | $16M | $13M | |
| Operating Expenses | $57M | $54M | $33M | |
| Operating Income | $-57M | $-54M | $-31M | |
| Other Non-op | $6M | $9M | $3M | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-51M | $-46M | $-28M | |
| EPS (Basic) | $-1.58 | $-1.45 | $-2.66 | |
| EPS (Diluted) | $-1.58 | $-1.45 | $-2.66 | |
| Shares (Basic) | 32,345,525 | 31,350,725 | 10,460,335 | |
| Shares (Diluted) | 32,345,525 | 31,350,725 | 10,460,335 | |
| EBITDA | $-57M | $-54M | $-31M |
대차대조표 16
| 지표 | 추세 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $35M | $76M | $75M | |
| Short-term Investments | $78M | $75M | $20M | |
| Prepaid Expense | $3M | $2M | $2M | |
| Other Current Assets | $199.0K | $157.0K | $74.0K | |
| Current Assets | $116M | $153M | $97M | |
| Total Assets | $116M | $160M | $97M | |
| Accounts Payable | $1M | $1M | $186.0K | |
| Accrued Liabilities | $4M | $3M | $5M | |
| Current Liabilities | $5M | $4M | $6M | |
| Total Liabilities | · | $4M | $6M | |
| Paid-in Capital | $458M | $451M | $341M | |
| Retained Earnings | $-346M | $-295M | $-250M | |
| AOCI | $120.0K | $230.0K | $30.0K | |
| Stockholders' Equity | $111M | $156M | $91M | |
| Liabilities + Equity | $116M | $160M | $97M | |
| Shares Outstanding | · | · | 0 |
현금 흐름 6
| 지표 | 추세 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $6M | $5M | $5M | |
| Operating Cash Flow | $-46M | $-42M | $-24M | |
| Investing Cash Flow | $5M | $-62M | $13M | |
| Stock Issued | $0 | $106M | · | |
| Net Stock Activity | $0 | $106M | · | |
| Financing Cash Flow | $275.0K | $105M | $86M |
수익성 5
| 지표 | 추세 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | · | -1537.0% | |
| Net Margin | · | · | -1393.8% | |
| EBITDA Margin | · | · | -1537.0% | |
| ROA | -36.9% | -35.5% | -43.0% | |
| ROE | -42.3% | -27.9% | -29.5% |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 22.8 | 34.3 | 17.1 | |
| Quick Ratio | 22.2 | 34.0 | 16.8 |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 |
가치 평가 (TTM) 8
| 지표 | 추세 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | · | · | $2M | |
| Net Income TTM | $-51M | $-46M | $-28M | |
| Market Cap | · | · | $0 | |
| P/E | -3.7 | -3.1 | -2.0 | |
| P/S | · | · | 0.0 | |
| P / Tangible Book | · | · | 0.0 | |
| P / Cash Flow | · | · | 0.0 | |
| Earnings Yield | -26.7% | -32.2% | -49.1% |
손익계산서 12
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | $0 | $2M | |
| R&D Expense | $7M | $7M | $10M | $7M | $15M | $14M | $13M | $6M | $5M | $6M | $5M | |
| SG&A Expense | $5M | $4M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $12M | $11M | $14M | $12M | $20M | $18M | $17M | $11M | $9M | $9M | $9M | |
| Operating Income | $-12M | $-11M | $-14M | $-12M | $-20M | $-18M | $-17M | $-11M | $-9M | $-9M | $-7M | |
| Other Non-op | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Net Income | $-11M | $-10M | $-13M | $-10M | $-18M | $-16M | $-15M | $-8M | $-7M | $-8M | $-6M | |
| EPS (Basic) | $-0.33 | $-0.30 | $-0.40 | $-0.32 | $-0.56 | $-0.52 | $-0.45 | $-0.25 | $-0.23 | $69.07 | $-0.35 | |
| EPS (Diluted) | $-0.33 | $-0.30 | $-0.40 | $-0.32 | $-0.56 | $-0.52 | $-0.45 | $-0.25 | $-0.23 | $69.07 | $-0.35 | |
| Shares (Basic) | 32,559,704 | -64,510,079 | 32,464,893 | 32,195,366 | 32,195,345 | -61,745,925 | 32,143,336 | 31,913,887 | 29,039,427 | -8,109,004 | 18,194,682 | |
| Shares (Diluted) | 32,559,704 | -64,510,079 | 32,464,893 | 32,195,366 | 32,195,345 | -61,745,925 | 32,143,336 | 31,913,887 | 29,039,427 | -8,109,004 | 18,194,682 | |
| EBITDA | $-12M | · | $-14M | $-12M | $-20M | · | $-17M | $-11M | $-9M | · | $-7M |
대차대조표 17
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $35M | $32M | $42M | $65M | $76M | $77M | $96M | $177M | $75M | $102M | |
| Short-term Investments | $68M | $78M | $84M | $83M | $80M | $75M | $75M | $70M | $17M | $20M | $0 | |
| Prepaid Expense | $3M | $3M | $3M | $2M | $2M | $2M | $5M | $378.0K | $786.0K | $2M | $974.0K | |
| Other Current Assets | $248.0K | $199.0K | $253.0K | $173.0K | $263.0K | $157.0K | $101.0K | $130.0K | $108.0K | $74.0K | $77.0K | |
| Current Assets | $108M | $116M | $119M | $127M | $146M | $153M | $157M | $167M | $194M | $97M | $103M | |
| Other Non-current Assets | · | · | · | · | $62.0K | · | · | · | · | · | · | |
| Total Assets | $108M | $116M | $128M | $137M | $146M | $160M | $175M | $189M | $195M | $97M | $103M | |
| Accounts Payable | $2M | $1M | $4M | $2M | $3M | $1M | $1M | $2M | $531.0K | $186.0K | $2M | |
| Accrued Liabilities | $3M | $4M | $5M | $5M | $4M | $3M | $3M | $4M | $4M | $5M | $3M | |
| Current Liabilities | $5M | $5M | $9M | $7M | · | $4M | · | · | · | $6M | $5M | |
| Total Liabilities | · | · | · | · | $7M | · | $4M | $6M | $5M | · | $5M | |
| Paid-in Capital | $459M | $458M | $456M | $454M | $452M | $451M | $449M | $448M | $446M | $341M | $339M | |
| Retained Earnings | $-357M | $-346M | $-337M | $-324M | $-313M | $-295M | $-279M | $-264M | $-256M | $-250M | $-242M | |
| AOCI | $8.0K | $120.0K | $117.0K | $76.0K | $121.0K | $230.0K | $441.0K | $-23.0K | $7.0K | $30.0K | · | |
| Stockholders' Equity | $102M | $111M | $119M | $130M | $139M | $156M | $171M | $183M | $190M | $91M | $98M | |
| Liabilities + Equity | $108M | $116M | $128M | $137M | $146M | $160M | $175M | $189M | $195M | $97M | $103M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | 0 | 0 |
현금 흐름 6
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $759.0K | $1M | $2M | |
| Operating Cash Flow | $-9M | $-12M | $-10M | $-9M | $-15M | $-11M | $-20M | $-6M | $-6M | $-7M | $-4M | |
| Investing Cash Flow | $10M | $14M | $75.0K | $-13M | $3M | $10M | $624.0K | $-75M | $3M | $-20M | $0 | |
| Stock Issued | · | $0 | $0 | · | · | $0 | $0 | $0 | $106M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $106M | · | · | |
| Financing Cash Flow | · | $0 | $274.0K | · | · | $0 | $0 | $-27.0K | $105M | $0 | $87M |
수익성 5
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -372.6% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | -317.6% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | -372.6% | |
| ROA | -8.4% | · | -8.5% | -6.4% | -10.7% | · | -10.5% | -7.7% | -6.8% | · | -12.3% | |
| ROE | -8.8% | · | -8.9% | -6.6% | -11.1% | · | -10.9% | 107.4% | -7.0% | · | -13.0% |
유동성 및 지급능력 2
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.3 | · | 13.1 | 17.6 | · | · | · | · | · | · | 20.4 | |
| Quick Ratio | 19.7 | · | 12.8 | 17.3 | · | · | · | · | · | · | 20.2 |
효율성 1
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 |
가치 평가 (TTM) 5
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-52M | · | $-56M | $-51M | $-48M | · | $-36M | $-28M | $-26M | · | $-27M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | $0 | |
| P/E | -3.2 | · | -4.0 | -4.8 | -2.2 | · | -2.2 | -0.1 | -0.1 | · | -0.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Earnings Yield | -30.8% | · | -25.2% | -20.7% | -45.7% | · | -46.2% | -1071.0% | -1327.7% | · | -1273.5% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| 매출 | — | — | $2M | — |
| 영업이익률 % | — | — | -1537.0% | — |
| 순이익 | $-51M | $-46M | $-28M | $-30M |
| 희석 EPS | $-1.58 | $-1.45 | $-2.66 | $-165.20 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| 유동비율 | 22.8 | 34.3 | 17.1 | — |
| 당좌 비율 | 22.2 | 34.0 | 16.8 | — |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.